GlaxoSmithKline has rejected a £50bn bid from Unilever to acquire its consumer health joint venture with Pfizer, saying it “fundamentally undervalued” the business and its future prospects.
葛兰素史克(GlaxoSmithKline, GSK)拒绝了联合利华(Unilever)以500亿英镑收购其与辉瑞(Pfizer)的消费者健康合资企业的报价，称此举“从根本上低估了”该业务及其未来前景。
您已阅读5%（290字），剩余95%（5833字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。